Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76676 - 76700 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamibarotene	Investigational	TYROBP	7305	upregulated	tamibarotene results in increased expression of TYROBP mRNA	19q13.12	A24376
Tamibarotene	Investigational	UBA7	7318	upregulated	tamibarotene results in increased expression of UBA7 mRNA	3p21.31	A24376
Tamibarotene	Investigational	USP13	8975	downregulated	tamibarotene results in decreased expression of USP13 mRNA	3q26.33	A24376
Tamibarotene	Investigational	UTP20	27340	downregulated	tamibarotene results in decreased expression of UTP20 mRNA	12q23.2	A24376
Tamibarotene	Investigational	VASP	7408	upregulated	tamibarotene results in increased expression of VASP mRNA	19q13.32	A24376
Tamibarotene	Investigational	VAV1	7409	upregulated	tamibarotene results in increased expression of VAV1 mRNA	19p13.3	A20516
Tamibarotene	Investigational	VAV3	10451	downregulated	tamibarotene results in decreased expression of VAV3 mRNA	1p13.3	A20516
Tamibarotene	Investigational	VDAC1P3	100310838	downregulated	tamibarotene results in decreased expression of VDAC1P3 mRNA	Xq21.31	A24376
Tamibarotene	Investigational	VEGFA	7422	upregulated	tamibarotene results in increased expression of VEGFA mRNA	6p21.1	A24381
Tamibarotene	Investigational	VIM	7431	downregulated	tamibarotene results in decreased expression of VIM mRNA	10p13	A24376
Tamibarotene	Investigational	WARS	7453	upregulated	tamibarotene results in increased expression of WARS mRNA	14q32.2	A24376
Tamibarotene	Investigational	WNK1	65125	downregulated	tamibarotene results in decreased expression of WNK1 mRNA	12p13.33	A24376
Tamibarotene	Investigational	XBP1	7494	upregulated	tamibarotene results in increased expression of XBP1 mRNA	22q12.1	A20516
Tamibarotene	Investigational	XPOT	11260	downregulated	tamibarotene results in decreased expression of XPOT mRNA	12q14.2	A24376
Tamibarotene	Investigational	ZBTB16	7704	downregulated	tamibarotene results in decreased expression of ZBTB16 mRNA	11q23.2	A24376
Tamibarotene	Investigational	ZCCHC24	219654	upregulated	tamibarotene results in increased expression of ZCCHC24 mRNA	10q22.3	A24376
Tamibarotene	Investigational	ZNF148	7707	downregulated	tamibarotene results in decreased expression of ZNF148 mRNA	3q21.2	A24376
Tamibarotene	Investigational	ZNF263	10127	downregulated	tamibarotene results in decreased expression of ZNF263 mRNA	16p13.3	A24376
Tamibarotene	Investigational	ZNF267	10308	downregulated	tamibarotene results in decreased expression of ZNF267 mRNA	16p11.2	A24376
Tamoxifen	Approved Investigational	ABCB1	5243	upregulated	[Tamoxifen results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA	7q21.12	A21862
Tamoxifen	Approved Investigational	ABCC11	85320	upregulated	Tamoxifen results in increased expression of ABCC11 mRNA	16q12.1	A21099
Tamoxifen	Approved Investigational	ACAP2	23527	upregulated	Tamoxifen results in increased expression of ACAP2 mRNA	3q29	A3616
Tamoxifen	Approved Investigational	ACTR1B	10120	downregulated	Tamoxifen results in decreased expression of ACTR1B mRNA	2q11.2	A3616
Tamoxifen	Approved Investigational	ADAM22	53616	downregulated	Tamoxifen results in decreased expression of ADAM22 mRNA	7q21.12	A21112
Tamoxifen	Approved Investigational	AGR2	10551	upregulated	Tamoxifen results in increased expression of AGR2 mRNA	7p21.1	A24382

Displaying entries 76676 - 76700 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability